Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05103046 · ClinicalTrials.gov registry record · Phase 1

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by 1200 Pharma.

Recruiting
Registry status
Phase 1
Development phase
68
Enrollment target
5
Study locations

NCT05103046 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by 1200 Pharma. The registered enrollment target is 68 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (65% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05103046, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by 1200 Pharma.

RECRUITING
Registry status
Phase 1
Development phase
68 participants
Enrollment target
5
Study locations

Study Summary

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of UCT-03-008 in patients with advanced solid tumors.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG UCT-03-008

Study Locations (5)

California

  • UCLA - JCCC Clinical Research Unit - Los Angeles
  • Torrance Memorial - Torrance

Texas

  • Mary Crowley Cancer Research - Dallas
  • START (South Texas Accelerated Research Therapeutics) - San Antonio

Georgia

  • Winship Institute of Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2021-12-23
Est. Completion 2025-12-15
Phase Phase 1

Sponsor

1200 Pharma

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05103046

The ClinicalTrials.gov registry entry for NCT05103046 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (65% lower). The listed sponsor is 1200 Pharma, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which UCT-03-008 is the first listed.

NCT05103046 reports 5 study locations spanning 3 distinct geographic areas - top geographies include California, Texas, Georgia.

Frequently Asked Questions

What is clinical trial NCT05103046 about?

NCT05103046 is a clinical study titled "First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors". This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of UCT-03-008 in patients with advanced solid tumors.

What is the current status of trial NCT05103046?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2021-12-23. Estimated completion is 2025-12-15.

What conditions does trial NCT05103046 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT05103046?

The interventions under investigation include: UCT-03-008 (DRUG).

Who is sponsoring clinical trial NCT05103046?

This trial is sponsored by 1200 Pharma, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05103046 being conducted?

This trial has 5 study locations across California, Georgia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.